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TubulogenesisFgfrl1 is a novel member of the ﬁbroblast growth factor receptor family. Its extracellular domain resembles
the four conventional Fgfrs, while its intracellular domain lacks the tyrosine kinase domain necessary for Fgf
mediated signal transduction. During embryonic development Fgfrl1 is expressed in the musculoskeletal
system, in the lung, the pancreas and the metanephric kidney. Targeted disruption of the Fgfrl1 gene leads to
the perinatal death of the mice due to a hypoplastic diaphragm, which is unable to inﬂate the lungs. Here we
show that Fgfrl1-/- embryos also fail to develop the metanephric kidney. While the rest of the urogenital
system, including bladder, ureter and sexual organs, develops normally, a dramatic reduction of ureteric
branching morphogenesis and a lack of mesenchymal-to-epithelial transition in the nephrogenic
mesenchyme result in severe renal dysgenesis. The failure of nephron induction might be explained by
the absence of the tubulogenic markers Wnt4, Fgf8, Pax8 and Lim1 at E12.5 of the mutant animals. We also
observed a loss of Pax2 positive nephron precursor cells and an increase of apoptosis in the cortical zone of
the remnant kidney. Fgfrl1 is therefore essential for mesenchymal differentiation in the early steps of
nephrogenesis.
© 2009 Elsevier Inc. All rights reserved.Introduction
The mammalian kidney, or metanephros, develops through a
complex series of mesenchymal–epithelial interactions when the
ureteric bud, an outgrowth of the nephric duct, is induced and invades
the metanephric mesenchyme on the level of the hindlimb bud.
During this invasion process the epithelial ureteric bud undergoes a
series of branching events, ultimately forming the collecting duct
system of the adult kidney, which is responsible for urine ﬂow to the
bladder. Branching of the ureteric bud and formation of invasive
ureteric tips is induced and driven by signals from the metanephric
mesenchyme (Grobstein, 1956; Saxen and Sariola, 1987). The ureteric
tips in turn induce the proliferation, condensation and ultimately the
conversion of adjacent mesenchymal cells into epithelial nephron
progenitors (Mori et al., 2003). Although this reciprocal inductive
system has been extensively studied and is now well described,
relatively little is known about the molecular events that take place
during the conversion of mesenchymal cells into the earliest nephron
progenitor, the renal vesicle. Mesenchymal cells in proximity to the
ureter tips proliferate and condense to form the cap mesenchymeesearch, University of Bern,
4963.
ll rights reserved.structure. A subset of the cap cells differentiates into the pretubular
aggregate (Sariola, 2002) which then undergoes a mesenchymal to
epithelial transition to form a polarized epithelial vesicle. This renal
vesicle further differentiates into the comma-shaped body, followed
by the S-shaped body and ﬁnally matures into nephron epithelium
(Costantini, 2006; Dressler, 2006). TheWnt family of growth factors is
believed to play a key instructive role in this process, with Wnt9b and
Wnt11 being secreted from the ureteric bud into the adjacent
mesenchyme (Majumdar et al., 2003; Schmidt-Ott and Barasch,
2008) and Wnt4 being synthesized by the condensing mesenchymal
cells themselves (Schedl, 2007). Indeed, genetic ablation ofWnt4 and
Wnt9b in mice leads to a failure of mesenchymal induction and
consequently to the absence of differentiated nephrons (Carroll et al.,
2005; Stark et al., 1994). In this context, Wnt9b acts upstream of
Wnt4, as missing inductive Wnt9b signaling from the ureter tips
results in an absence of Wnt4 expression in the mesenchymal
aggregates (Carroll et al., 2005). Based on in vitro cell induction
assays (Kispert et al., 1998; Stark et al., 1994) and mouse mutant
studies Wnt4 itself is necessary and sufﬁcient to drive the transition
from aggregated mesenchymal cells into the epithelium of the
polarized renal vesicles (Stark et al., 1994).
The ﬁbroblast growth factors and their receptors represent
another signaling system that is required for the early steps of
nephrogenesis both in the ureter and in the metanephric mesen-
chyme. Various Fgf ligands, among them Fgf2, Fgf7, Fgf8 and Fgf10, are
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developing kidney (Barasch et al., 1997; Grieshammer et al., 2005;
Qiao et al., 1999; Ohuchi et al., 2000), whereby Fgf7 and Fgf10 signal
through Fgfr2IIIb in the ureteric epithelium, while Fgf2 and Fgf8 bind
to and activate Fgfr1 and Fgfr2 in the metanephric mesenchyme
(Bates, 2007). Fgf7 and Fgf10 as well as Fgfr1 and Fgfr2 seem to have
overlapping and partly redundant roles as single mutant mice display
only mild kidney defects (Bates, 2007). However, both expression of a
soluble, dominant negative Fgfr (Celli et al., 1998) as well as double,
tissue speciﬁc deletions of Fgfr1 and Fgfr2 in the metanephric
mesenchyme (Poladia et al., 2006) led to renal aplasia, highlighting
the crucial importance of Fgfr signaling in kidney development (Bates,
2007). Conditional deletion of Fgf8 from the metanephric mesen-
chyme also results in severe renal defects due to an arrest of nephron
differentiation at the renal vesicle stage. This arrest is characterized by
an absence of Wnt4 and Lim1 expression and by an increase of
apoptosis in the cortical zone (Grieshammer et al., 2005; Perantoni et
al., 2005).
In this study we address the function of a novel member of the
Fgfr family, the ﬁbroblast growth factor receptor-like 1 (Fgfrl1) in
the development of the metanephric kidney. Fgfrl1 closely resembles
the four conventional Fgfrs, as its ectodomain has three extracellular
Ig-like domains sharing up to 50% sequence similarity with the other
receptors (Wiedemann and Trueb, 2000; 2001). Its intracellular
domain, however, comprises only about 100 amino acids and lacks
the tyrosine kinase domain that would be required for Fgf ligand
mediated autophosphorylation and signal transduction (Sleeman et
al., 2001; Trueb et al., 2003). During embryonic development Fgfrl1
is expressed in cartilage, bone, muscles of the diaphragm and
tongue, in the pancreas and in the lung (Kim et al., 2001; Trueb and
Taeschler, 2006). In the developing kidney Fgfrl1 expression is
upregulated in the renal vesicles of the differentiating metanephric
mesenchyme (Brunskill et al., 2008; www.genepaint.org). Mice with
a targeted disruption of the Fgfrl1 gene (Baertschi et al., 2007) die
immediately after birth due to a hypoplastic diaphragm, which
renders the newborn animals unable to inﬂate the lungs. In addition
there are subtle alterations in the bones of the skull and in the long
bones of the limbs. The most striking phenotype in the otherwise
normally developed mice, however, is the fully penetrant severe
dysgenesis of both metanephric kidneys. In this study we present
evidence that this renal dysgenesis in Fgfrl-/- mice is caused by a
failure of metanephric mesenchymal cells to differentiate into
nephron epithelium accompanied by severe branching defects of
the ureter.
Materials and methods
Transgenic animals
Fgfrl1-/- mice were generated and bred as previously described
(Baertschi et al., 2007). Littermates were used for all comparative
experiments between wild-type and transgenic embryos. For an
exactly timed pregnancy, the noon of the day, on which a vaginal plug
was detected, was considered as E0.5.
Histology and immunohistochemistry
Embryos of different developmental stages were dissected, ﬁxed in
4% paraformaldehyde (PFA) and cut into 5-μm sections. The sections
were stained with Mayer's hemalaun and eosin (H&E). For immuno-
histochemistry, the sections were boiled in citrate buffer to unmask
the antigens, washed in Tris buffered saline (TBS) containing 0.025%
Triton X-100 and blockedwith 3% bovine serum albumin (BSA) in TBS.
The following primary antibodies were used: anti-pan cytokeratin
monoclonal antibody PCK-26 (1:600, Sigma), anti-calbindin D28K
monoclonal antibody CB-955 (1:100, Sigma), anti-laminin polyclonalantibody 143 (1:200, a kind gift from Dr. M. Chiquet, University of
Bern), anti-Pax2 polyclonal antibody PRB-276P (1:100, Covance,
Emeryville, CA), and anti-Wt1 polyclonal antibody C-19 (1:100,
Santa Cruz Biotechnology Inc.). After incubation overnight with the
primary antibody at 4 °C, the following secondary antibodies were
applied: TRITC conjugated goat anti-rabbit antibodies (1:400; Sigma)
and Cy2 conjugated goat anti-mouse antibodies (1:100; Jackson
Immunoresearch Laboratories). For detection of Fgfrl1, the polyclonal
goat antibodies FGFR5β (1:100; R&D Systems) and FGFR5 C-20
(1:100; Santa Cruz Biotechnology Inc.) were used. To detect the
bound antibodies, secondary rabbit anti-goat antibodies conjugated
with alkaline phosphatase were employed (1:150, Sigma). The color
reaction was performed with bromochloroindolyl phosphate and
nitroblue tetrazolium substrate.
Metanephric organ cultures
Kidney rudiments were dissected from E11.5 embryos and
cultured for up to 96 h on polycarbonate transwell ﬁlters (0.4 μm,
Falcon 3180) at the liquid–gas interphase (Saxen and Lehtonen,
1987). Dulbecco's modiﬁed Eagle's medium supplemented with 10%
fetal bovine serum, non-essential amino acids and penicillin/
streptomycin served as culture medium. For immunoﬂuorescence
experiments, the organ cultures were excised together with the
transwell ﬁlters, ﬁxed for 30 min with 4% PFA in PBS, permeabilized
for 1 h with 1% Triton X-100 in PBS and blocked with 3% BSA in
PBS. After incubation overnight at 4 °C with primary antibodies, the
cultures were washed for a total of 10 h with several changes of
0.1% Triton X-100 in PBS. Fluorescently labeled secondary anti-
bodies were added and incubation was repeated overnight. After
extensive washing as above, the cultures were mounted with
Mowiol on glass slides and photographed under a Nikon Eclipse
E1000 microscope.
Proliferation and apoptosis assays
Selected tissues of E14.5 littermates were ﬁxed in 4% PFA and
embedded in Tissue-Tek OCT Compound (Sakura Fintek, Zoeter-
woude, the Netherlands). The frozen tissues were sectioned at 7 μm
and ﬁxed again in PFA. After permeabilization with 0.1% Triton X-100
in PBS, the sections were blocked with 3% BSA in PBS. Apoptotic cells
were detected by TUNEL utilizing the In situ Cell Death Detection Kit
(Roche Diagnostics) according to the manufacturer's instructions. Cell
proliferationwas determined in whole-mount organ cultures with the
BrdU Labeling and Detection Kit I (Roche Diagnostics). For this
purpose, the organ cultures were incubated at 37 °C with BrdU
containing labeling medium (1:1000). After 2 h the specimens were
ﬁxed with 70% ethanol, permeabilized with 1% Triton X-100, blocked
with 3% BSA and incubatedwith amouse antibody against BrdU (1:10,
Roche Diagnostics) as well as with a rabbit antibody against laminin
(see above). After extensive washing, the corresponding secondary
antibodies were added, a ﬂuorescein conjugated sheep anti-mouse Ig
(1:10, Roche Diagnostics) and the Cy3 conjugated goat anti-rabbit Ig
(see above).
Quantitative PCR
Total RNA was extracted from pooled kidney rudiments (n=6–9)
of mutant and wild-type embryos using the RNeasy kit from Qiagen
GmbH (Hilden, Germany). The RNA was transcribed into ﬁrst strand
cDNA by reverse transcriptase from Moloney Murine Leukemia Virus
(MMLV, Stratagene). Primer pairs for selected gene products (Table
S1) were designedwith the Probe Library Tool from Roche Diagnostics
and ordered from Microsynth AG (Balgach, Switzerland). The cDNAs
were quantiﬁed by real time PCR utilizing the ABI 7500 platform
(Applied Biosystems).
Fig. 1. Expression of Fgfrl1 in wild-type E15.5 kidneys. (A) Immunohistochemistry with
a polyclonal antibody against the Fgfrl1 ectodomain reveals Fgfrl1 protein in
nephrogenic structures of the cortical zone, with strongest signal observed in renal
vesicles, comma and S-shaped bodies. The cortical and medullary stroma and the fully
differentiated glomeruli display no Fgfrl1 protein. The 40×magniﬁcation shows an area
from the cortical nephrogenic zone. Nascent nephrons ranging from renal vesicles to S-
shaped bodies are indicated by black arrows. The nascent nephrons contain Fgfrl1, but
the surrounding cells do not. The 100× magniﬁcation shows a renal vesicle from the
cortical zone. Fgfrl1 protein is enriched at sites of cell–cell contact in the newly formed
epithelium of the renal vesicle (arrow heads). (B) Quantiﬁcation of the Fgfrl1 mRNA in
the developing kidneys. Fgfrl1 expression is maximal around E16 in the wild-type
kidneys (l) ●. Before E12 and after birth, expression is very low. Kidney rudiments of
Fgfrl1 deﬁcient mice (◆) do not express Fgfrl1.
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In order to generate hybridization probes for various genes,
cDNA from E16.5 kidneys was ampliﬁed by PCR with the primer
pairs listed in Table S2 and the products were subcloned into the
expression vector pSPT19 (Roche). Riboprobes were transcribed
from the linearized vectors in the presence of digoxigenin-labeled
UTP using the DIG RNA Labeling Kit (SP6/T7) (Roche).
Whole-mount in situ hybridization was carried out by established
procedures (Piette et al., 2008; Wilkinson and Nieto, 1993) with
modiﬁcations described on the GUDMAP gene expression database
(http://www.gudmap.org/Research/Protocols/ McMahon.html).
Brieﬂy, kidneys from 12.5- and 14.5-day-old embryos were dissected
and ﬁxed overnight in 4% PFA. The kidneys were dehydrated through a
gradedmethanol series (25%, 50%, 75%, 100%) diluted in PBS containing
0.1% Tween 20 and then stored at -20 °C. The sampleswere rehydrated,
bleached for 30 min with 6% hydrogen peroxide and digested for
15 min with Proteinase K (10 μg/ml). The tissues were reﬁxed in 0.2%
glutaraldehyde/4% PFA, prehybridized for 2 h at 68 °C in hybridization
solution (50% formamide, 5X SSC (saline-sodium citrate), 1% SDS,
50 μg/ml yeast t-RNA, 50 μg/ml heparin) and incubated overnight at
68 °C with the riboprobes. After high stringency washes (50%
formamide, 5X SSC, 1% SDS) at 68 °C, the samples were blocked for
2 h at RTwith 3% BSA in TBST and incubated overnight at 4 °Cwith pre-
absorbed anti-digoxigenin Fab fragments conjugated with alkaline
phosphatase (Roche, 1:2000). Following extensive washes, BM Purple
(Roche)was added todevelop thehybridization signal. After 12–24hat
RT, the samples were photographed with a Nikon Coolpix 990 digital
camera.
Results
Fgfrl1 is expressed in nascent nephrons
In order to investigate the effects of Fgfrl1 deﬁciency on kidney
development, we analyzed the expression of Fgfrl1 in embryonic
kidneys from wild-type animals (Fig. 1). Microarray analysis and
in situ hybridization of Fgfrl1 mRNA had previously shown that
this receptor is expressed in the metanephric mesenchyme, with
strongest expression observed in renal vesicles and nascent
nephrogenic structures (Brunskill et al., 2008; www.gudmap.org;
www.genepaint.org). Our immunostaining experiments with a
polyclonal antibody against the extracellular domain of Fgfrl1
(Fig. 1A) conﬁrmed these data. The highest signal was detected in
differentiating renal vesicles and in the nephrogenic structures
derived thereof. Weaker staining was seen in the undifferentiated
mesenchymal cells and in the ureteric epithelium. No expression
was detected in the stromal cells surrounding the nephrogenic
structures. The larger magniﬁcations provided in Fig. 1A demon-
strate that Fgfrl1 protein was enriched at sites of cell–cell contact,
especially in the nascent epithelial bodies of renal vesicles and
further developed nephron precursors. The expression pattern
suggests that Fgfrl1 could be involved in the differentiation of
mesenchymal nephron precursor cells into tubular epithelial
structures. Quantiﬁcation of Fgfrl1 expression by real time PCR
was in good agreement with this observation (Fig. 1B). During
embryonic development of wild-type kidneys, the mRNA level for
Fgfrl1 increased from E11.5 to E12.5, probably reﬂecting the onset
of nephrogenesis. It reached a maximum around E16.5 and
decreased sharply thereafter when nephrogenesis eventually
ceases.
Severe bilateral renal dysgenesis
Heterozygous Fgfrl1+/- mice in a C57BL/6 background
displayed no overt phenotype (Baertschi et al., 2007). Theywere fertile and produced offspring in the expected Mendelian
ratio. Although our Fgfrl1-/- embryos were born alive and
appeared to be normally developed, they died immediately after
birth due to a hypoplastic diaphragm muscle, which was unable
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Fgfrl1-/- embryos for additional organ defects, we discovered
that the metanephric kidneys were missing in all of the examined
animals (Fig. 2). At embryonic day E18.5, only a small,Fig. 2. Severe renal dysgenesis in Fgfrl1-/-mice. The urogenital systemofwild-type (WT), hetero
rudimentary structures inplaceof thekidneys.Ureter, bladder and female andmalegonadsappearudimentary structure that was attached to the ureter was
found in place of the kidney. The rest of the urogenital system,
including testes, ovaries, bladder and ureter, appeared to be
normally developed.zygous (HET) and knock-out (KO) embryos is shown at E18.5. Themutantmice exhibit only
r tobenormally developed. a, adrenal gland; b, bladder;k, kidney;o, ovary; t, testis; u, ureter.
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Fig. 4.Whole kidney organ cultures recapitulate the developmental defects in Fgfrl1 deﬁcient mice. (A) Kidney rudiments of E11.5 wild-type and mutant littermates were dissected
and cultured on transwell ﬁlters for 96 h. The wild-type cultures develop normally with a symmetrical branching pattern and visible differentiation of the mesenchyme. The mutant
cultures show severely reduced and uncoordinated ureteric branching and a lack of tubulogenesis. Bar=200 μm. (B) Whole-mount immunoﬂuorescence with the ureteric bud
marker calbindin. Three representative examples are shown. (C) Statistical analysis of tip formation and (D) ureteric branching events after three days in culture. The wild-type
ureteric buds branch six to seven times, resulting in 55 tips (n=7). In contrast, the knock-out ureters branch only three to four times, resulting in 20 tips on the average (n=8).
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In order to investigate the time point and nature of the
developmental arrest of the kidney, sections containing the kidney
anlagen from E11.5 to E18.5 embryos were examined after H&EFig. 3. Severe defects in branching and mesenchymal differentiation. H&E staining of kid
mesenchymal differentiation are severely reduced. T-stage of the mutant ureteric bud and m
knock-out animals is still in the T-stage and tubulogenesis is not initiated. From E12.5 to E1
nephrons form in the mutant kidneys. Morphogenesis of the ureteric bud and collecting duct
to 100 μm for all panels except the two panels at the bottom where it is equal to 500 μm.staining (Fig. 3). At E11.5 the ureteric bud of wild-type and mutant
animals had begun to invade the metanephric mesenchyme and
branched once to form the so called “T-stage.” At E12.5 the ureter had
undergone another round of branching and the adjacentmesenchyme
had condensed around the ureter tips to form the capmesenchyme. Atney sections from E11.5 to E18.5 reveals that branching of the Fgfrl1-/- ureter and
etanephric mesenchyme appear to be normal at E11.5. At E12.5 the ureteric bud of the
8.5 nephrogenesis and ureteric branching proceed in the wild-type kidneys, while no
system is arrested after a few rounds of branching in the mutants. The scale bar is equal
Fig. 4 (continued).
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animals. In the Fgfrl1-/- embryos less mesenchymal condensation
was seen at this stage and renal vesicles were absent. The differences
became more striking at E14.5 when the wild-type ureter had
branched multiple times and the ﬁrst nephrons had formed. At this
stage branching of the mutant ureter appeared to have stalled and no
epithelial structures had differentiated from the metanephric mes-
enchyme. At E18.5 the kidney was almost fully developed in the wild-
type animals, whereas no nephrons had formed in themutant animals
and the ureteric collecting duct system showed severely reduced
branching. The absence of nephrons and the malformed uretericcollecting duct system indicated that Fgfrl1-/- mice lack functional
metanephric kidneys.
In addition to these in vivo studies we made use of the well
established whole kidney organ culture system (Saxen and Sariola,
1987; Saxen and Lehtonen, 1987) to gain insight into the effects of Fgfrl1
deﬁciency on kidney development. Kidney rudiments of wild-type and
mutant animals were dissected at E11.5 and cultured on polycarbonate
ﬁlter membranes. Fig. 4A shows a comparison of wild-type and mutant
kidney cultures grown over a time period of 96 hours. The wild-type
cultures developed normally with a rapidly and symmetrically branch-
ing ureteric bud and clear induction of nephrogenic structures in the
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and severely reduced branching together with little or no visible
differentiation of the mesenchyme. Branching of the mutant ureter
appeared irregular and less coordinated than that of the wild-type
ureter and mesenchymal condensation, pretubular aggregation and
tubulogenesis were greatly reduced or virtually absent.
Whole-mount immunoﬂuorescent staining of the kidney cultures
with the ureteric epitheliummarker calbindin allowed for a statistical
analysis of ureteric tips and branching events in wild-type andmutant
cultures after 72 h (Figs. 4B–D). While the wild-type ureters had
branched six to seven times forming about 55 tips, the Fgfrl1-/-
ureters had branched only three to four times resulting in an average
of 20 tips. The overall size of the mutant kidney cultures was greatly
reduced when compared to the cultures of wild-type littermates.
In combination, the in vivo studies and the organ cultures suggest
that the ureteric bud of Fgfrl1-/- embryos is initially induced by the
metanephric mesenchyme. It is able to undergo some rounds of
branching and tip formation. In this context it should be noted that
the ureteric bud undergoes more branching events in the organ
cultures than in the living animals. However, tubulogenesis of the
mesenchyme does not appear to be initiated at all, neither in the
organ cultures nor in vivo.
Absence of nephrogenic markers in the Fgfrl1-/- mesenchyme
The histological analysis of kidney development in the mutant
mice suggested a severe defect in branching morphogenesis and
mesenchymal differentiation that became apparent at E12.5. We
therefore extracted RNA from E12.5 and E14.5 kidney rudiments and
performed real-time RT-PCR to assess the expression of marker genes
known to be important for the early steps of nephrogenesis. Table 1
lists the full set of genes analyzed and the changes in the expression
levels between wild-type and mutant kidney rudiments. Although
many of the genes were slightly down-regulated in themutant kidney
rudiments, we found a number of genes that showed a striking
reduction in their expression levels. The most pronounced reduction
was observed for the transcription factors Pax8 and Lim1 as well as for
the secreted factors Wnt4 and Fgf8, all of which are marker genes of
the tubulogenic program (Carroll et al., 2005). Pax2 expression, which
occurs both in the uninduced mesenchyme and in the developing
nephrons (Narlis et al., 2007) was also signiﬁcantly reduced, albeit not
to the same extent as Pax8. The expression of Eya1, Six2, and Wt1,
which, together with Pax2, deﬁne the uninduced mesenchymeTable 1
Genes showing altered expression in kidneys of Fgfrl1 knock-out embryos.
Gene Fold change (wt/ko)
E12.5 E14.5
Wnt4 13.3 4.2
Pax8 9.6 7.1
Fgf8 9.2 12.1
Lim/Lhx1 7.7 18.3
Fgfrl1 6.8 21.2
Pax2 5.4 4.1
Eya1 3.1 5.4
Ret 3.1 8.9
Gdnf 3.0 3.4
Osr1 2.8 2.1
Emx2 2.4 5.2
Fgfr1 2.1 1.3
Wnt11 2.0 2.0
Wt1 2.0 3.1
Wnt9b 1.9 1.7
Six1 1.6 1.5
Fgfr2 1.5 1.3
Six2 0.7 4.3
Ehf 0.3 0.7
Gapdh 1.0 1.0(Brodbeck and Englert, 2004), was largely intact. Likewise, the
ureteric genes Wnt9b, Wnt11 and c-Ret were still expressed at E12.5.
These expression data point to a defect in tubulogenesis due to failure
of the mesenchyme to express tubulogenic genes.
We next set out to characterize the mutant mesenchyme and the
apparent lack of nephrogenesis in detail. To this end we performed
immunohistochemistry with antibodies against the mesenchymal
markers Pax2 and Wt1 on kidney sections and in whole organ
cultures. We also analyzed the expression of the ureteric genesWnt9b
andWnt11 and of the tubulogenic markers Pax8, Fgf8,Wnt4 and Lim1
by whole-mount in situ hybridization of E12.5 and E14.5 kidneys.
Pax2 is expressed during the entire development of the meta-
nephros, both in the ureteric collecting duct system and in the
mesenchymal compartment. In the renal vesicle, Pax2 and Pax8 act in
concert to drive differentiation from nephron progenitors of the renal
vesicle stage to the end of nephron development. Pax2 homozygous
mutant mice form the pronephros and the mesonephros but fail to
induce the metanephros (Narlis et al., 2007). As shown by
immunohistochemisty (Fig. 5), Pax2 was normally produced at
E12.5 and E14.5 in the ureteric compartment of the mutant kidney.
However, the mesenchymal compartment showed some reduction in
Pax2 synthesis when compared to wild-type kidneys of the same
developmental stage. At E12.5 the ﬁrst renal vesicles and comma-
shaped bodies had appeared in the wild-type kidneys and both were
found to strongly produce Pax2. The condensing cells of the cap
mesenchyme and the pretubular aggregates around the cytokeratin-
positive ureteric tips showed high levels of Pax2 protein as well. In
contrast, the mutant kidneys completely lacked the epithelial Pax2-
positive nephron precursors. Although the mesenchymal cells still
synthesized Pax2, only little Pax2-positive condensation and no
epithelialization was present around the ureter tips. At E14.5 the
differences became even more striking. Numerous Pax2-positive
nephron precursors had formed in the wild-type kidneys and Pax2
producing cap mesenchyme surrounded the ureteric tips in the
cortical zone, while no nephron differentiation was found in the
mutant kidneys. Here, only few isolated cells appeared to synthesize
Pax2 and no Pax2-positive cap mesenchyme was observed. The ﬁve-
fold reduction in Pax2 expression (Table 1) at E12.5 and E14.5 was
most likely due to the absence of the condensing cap mesenchyme
and nephron precursor structures, both of which strongly express
Pax2 in the wild-type kidneys.
We also stained the kidney sections for the presence of Wt1
protein (Fig. 5).Wt1 plays a dual role during kidney development as it
is expressed in the metanephric mesenchyme at the earliest stages of
nephrogenesis (Donovan et al., 1999) and later on in the podocytes of
the glomerulus (Morrison et al., 2008). In the early mesenchyme it
speciﬁes, together with Pax2, Eya1 and Six2 (Brodbeck and Englert,
2004), the nephrogenic precursor cell population, which eventually
differentiates into nephron epithelium. Utilizing speciﬁc antibodies
and sections from E12.5 embryos, we observed that Wt1 expression
was relatively intact in the mutant kidneys, although a lack of
condensation and epithelialization was also evident when compared
to the wild-type sections. Staining of E14.5 sections from wild-type
embryos displayed someWt1 protein in the cortical mesenchyme and
a strong, focal signal in the podocytes of the nascent glomeruli. As
expected, no such signal was detected in the sections from the E14.5
mutant animals, providing further evidence for the absence of
nephron differentiation (Fig. 5). We also tried to stain the kidney
sections with a polyclonal antibody against Six2 but could not obtain
any speciﬁc signal (not shown). We therefore analyzed its expression
by whole-mount in situ hybridization (see below in Fig. 7, bottom). In
good agreement with the real-time PCR results, Six2 expression was
intact in the Fgfrl1 deﬁcient kidneys. Taken together, the Pax2, Wt1
and Six2 expression analysis suggested that the uninduced meta-
nephric mesenchyme is present at E12.5, but fails to initiate
nephrogenesis.
Fig. 5. Analysis of marker gene expression. Parafﬁn sections from kidneys of Fgfrl1 wild-type and knock-out littermates of E12.5 and 14.5 were stained with antibodies against
cytokeratin, Pax2 andWt1. In the Fgfrl1-/- mice of E12.5, synthesis of Pax2 appears to be normal in the ureteric bud and in the uninduced mesenchymal cells. The ﬁrst Pax2 positive
renal vesicles have formed in the wild-type kidneys, but aremissing in themutants. At E14.5 there is a marked reduction of Pax2 positive mesenchymal cells in the Fgfrl1-/- mice and
no nephrogenesis has taken place. Wt1, a marker for the uninduced mesenchyme and for podocytes, is still produced in the mutant mesenchyme at E12.5. However, noWt1-postive
podocytes are detected at E14.5 in the mutant kidneys, reﬂecting a loss of nephron differentiation. Podocytes of the wild-type glomeruli strongly express Wt1 at E14.5. Bar=100 μm
for E12.5 and 200 μm for E14.5.
114 S.D. Gerber et al. / Developmental Biology 335 (2009) 106–119We also analyzed the expression of Pax2 and Wt1 and the lack of
tubulogenesis in our kidney cultures. Whole-mount staining of the
cultures with antibodies against Pax2 and Wt1 conﬁrmed the results
described above (Fig. 6). Expression of Pax2 appeared to be largely
intact in the ureteric bud of the Fgfrl1-/- cultures but was found to be
reduced in the mesenchymal compartment where no nephrogenesis
occurred. This was also reﬂected by a lack of Wt1-positive podocytesin the mutant cultures, whereas such podocytes were clearly present
in the wild-type cultures. Laminin staining of the kidney cultures
provided further evidence for the failure of tubulogenesis in the
mutant cultures. While an antibody against this marker for basement
membranes stained the ureteric epithelium and the newly formed
epithelia of the nascent nephrons in the wild-type cultures, it stained
only the ureteric bud in the mutant cultures. This suggested that no
Fig. 6.Whole-mount immunoﬂuorescence of Fgfrl1-/- organ cultures conﬁrms the defect of nephron differentiation. Organ cultures from wild-type and knock-out littermates were
ﬁxed after 3 days in culture and stained with antibodies against laminin, calbindin, Wt1 and Pax2. The antibodies against laminin stain the epithelium of the ureter and the newly
formed nephrons in the wild-type cultures. In the Fgfrl1 knock-out cultures, only the ureteric epithelium is stained, reﬂecting the defect in epithelialization of nephron precursors.
Pax2 appears to be present in the ureteric bud of the wild-type and knock-out cultures, but the amount of this marker is severely reduced in themesenchyme. Very few Pax2-positive
mesenchymal cells are clustered around the mutant ureteric tips. In the wild-type cultures, Wt1 is produced in the podocytes of the glomeruli. No podocytes are present in the
mutant cultures. Bar=200 μm.
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kidney cultures.
The observed defect in nephrogenesis could be due to a loss of
inductive signaling from the invading ureter or due to a failure of the
mesenchyme to properly respond to those signals. The real-time PCR
data suggested that the inductive factorsWnt9b andWnt11 were still
expressed in the ureter, while the mesenchyme remained unrespon-
sive and did not express the tubulogenic markers Wnt4, Fgf8, Pax8
and Lim1. To validate this, we utilized whole-mount in situ
hybridization (ISH) with probes against these gene products. As
shown in Fig. 7, the ISH experiments with E12.5 and E14.5 embryos
completely conﬁrmed the real-time PCR results. At E12.5 the ureteric
bud began to invade the metanephric mesenchyme and expressed
Wnt9b and Wnt11 (calbindin was included as a positive control)
both in the wild-type and in the mutant embryos, although
expression levels in the Fgfrl1 deﬁcient embryos were reduced to
some extent. In response to the inductive signals from the ureter, the
wild-type mesenchyme had initiated the tubulogenic program and
focally expressed Wnt4, Fgf8, Pax8 and Lim1. In contrast, none ofthese genes was expressed in themutant mesenchyme. At E14.5 there
was still no expression of any of the tubulogenic marker genes in the
Fgfrl1 deﬁcient kidneys, while we observed ongoing expression of
Wnt9b andWnt11 by the mutant ureteric stalks and tips, respectively.
Less proliferation and increased apoptosis in Fgfrl1-/- kidneys
It has previously been shown that a deletion of the factors Fgf8
and Wnt4 leads to an increase of apoptosis in the developing
kidney, especially in the differentiating nephrogenic cortical zone
(Grieshammer et al., 2005; Perantoni et al., 2005). We therefore
analyzed wild-type and mutant kidney sections of E14.5 for the
presence of apoptotic cells by TUNEL (Fig. 8A). In contrast to the
wild-type control, which displayed only sporadic cell death with no
obvious spatial accumulation, TUNEL staining of the Fgfrl1-/-
sections revealed a marked increase in the number of apoptotic
cells in the peripheral zone of the remnant kidney. The location of
the apoptotic cells and their co-staining with the epithelium marker
calbindin indicated that the apoptotic cells represented
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Fig. 8. Increased apoptosis in Fgfrl1-/- kidneys and reduced proliferation in mutant organ cultures. (A) TUNEL analysis of apoptotic cell death in cryosections of E14.5 wild-type and
mutant kidney rudiments. An increase of apoptosis is detected in the cortical zone of the knock-out sections. (B) Proliferation assay. Organ cultures from wild-type and knock-out
kidney rudiments were incubated for 2 h with BrdU and the incorporation was detected with an antibody against BrdU. The dramatically reduced incorporation into the knock-out
cultures demonstrates a pronounced lack of proliferation in the Fgfrl1 deﬁcient mesenchyme.
117S.D. Gerber et al. / Developmental Biology 335 (2009) 106–119mesenchymal cells of the cortical nephrogenic zone and not cells of
the invading ureter tips.
Using whole organ cultures we further investigated whether, in
addition to the increase of mesenchymal apoptosis, the rate of
proliferation was altered in the mutant mesenchyme (Fig. 8B). BrdU
was added to the cultures and after 2 h the incorporation was
visualized by staining with a monoclonal antibody against BrdU. Co-
staining with an antibody against laminin served to identify the
compartments where proliferation occurred. As expected, the wild-
type cultures displayed areas of rapid mesenchymal proliferation
around the tips of the ureter. The mesenchyme around the ureteric
tips of the mutant cultures, however, showed very little BrdU
incorporation when compared to the wild-type cultures, suggesting
a lack of proliferation in the nephrogenic mesenchymal cells.
Discussion
Fgfrl1 is expressed in the kidney
Fgfrl1 is expressed in the tubule forming metanephric mesen-
chyme, with strongest expression observed in renal vesicles and the
structures derived thereof. Previous data from in situ hybridization
experiments and microarray analysis are in agreement with our
immunohistochemical detection of Fgfrl1 in the metanephros. At
E15.5 the Fgfrl1 protein is primarily found in the differentiating
mesenchymal structures from the cortical zone of the growing kidney,
while no signal is detected in the medullary stromal cells and in fully
differentiated glomeruli. We observed strong focal staining of Fgfrl1Fig. 7. Whole-mount in situ hybridization of selected marker genes in E12.5 and E14.5 wild
probes, followed by detection of the probe with alkaline phosphatase coupled antibodies. The
mutant kidneys, as was calbindin used as a positive control. The tubulogenic marker genes
stages but could not be detected in the Fgfrl1 deﬁcient kidneys. Six2, a marker for the unin
indicate the kidneys of the Fgfrl1 knock-out embryos.protein at sites of cell-cell contact in the epithelia of renal vesicles and
further differentiated nephron precursors. This was not unexpected,
as we have previously shown that the Fgfrl1 protein is often enriched
at sites of cell–cell contact when overexpressed in mammalian cell
lines, such as human embryonic kidney cells, rhabdomyosarcoma cells
and osteosarcoma cells (Rieckmann et al., 2008; Trueb et al., 2003).
The expression and localization of Fgfrl1 during tubulogenesis
suggests that it might be involved in the differentiation and
epithelialization of mesenchymal cells into nephron epithelium.
Indeed, the metanephric mesenchyme of our Fgfrl1-/- mice
completely fails to undergo tubulogenesis, resulting in fully penetrant
dysgenesis of both kidneys in the homozygous knock-out mice.
Although the ureteric bud initially invades the metanephric mesen-
chyme and undergoes some rounds of branching, the mesenchyme
appears to be largely unresponsive and nephron differentiation is not
initiated. The rest of the urogenital system, including ureter, bladder
and gonads, appears to be unaffected by the Fgfrl1 deﬁciency. The
drastic effect on the development of the metanephros is particularly
intriguing as the mutant mice are otherwise well developed. As
reported previously, ourmice possess a hypoplastic diaphragm,which
leads to postnatal respiratory failure (Baertschi et al., 2007), and
display minor alterations in the bones of the skull and the limbs
(Rieckmann et al., 2009). Given the strong expression in cartilage,
tongue and diaphragm, the complete lack of the kidneys, which
express lower amounts of Fgfrl1 than those tissues, was not
anticipated. The lung, another organ that undergoes branching
morphogenesis and expresses Fgfrl1 in differentiating tubules
(www.genepaint.org), seems to be unaffected by the deﬁciency-type and Fgfrl1 deﬁcient kidneys. The tissues were hybridized with DIG-labeled RNA
ureteric marker genesWnt9b andWnt11 are expressed both in the wild-type and in the
Fgf8, Wnt4, Pax8 and Lim1 are expressed in the wild-type kidneys at both embryonic
duced mesenchyme, is expressed in wild-type and mutant kidneys. The white arrows
118 S.D. Gerber et al. / Developmental Biology 335 (2009) 106–119(Baertschi et al., 2007). It remains to be investigated in detail whether
the lung and other tubule containing organs might show minor
alterations in our Fgfrl1 deﬁcient animals.
Loss of Fgf8, Wnt4, Pax8 and Pax2 expression in Fgfrl1-/- kidneys
In order to understand the effects of Fgfrl1 deﬁciency on
tubulogenesis, we analyzed the expression of selected marker genes
in E12.5 and E14.5 kidney rudiments. Although most of the genes
analyzed were somewhat down-regulated in the mutant kidney
rudiments, expression of the gene products that are characteristic for
the ureteric bud, such as Wnt9b, Wnt11 and the ureteric bud marker
Ehf, was nearly intact. However, expression of those genes that
drive nephron differentiation in the metanephric mesenchyme was
dramatically reduced. At E12.5 and E14.5 the mRNA levels for Wnt4,
Fgf8, Pax8 and Lim1 were reduced about tenfold and none of them
could be detected by in situ hybridization, whereas they were readily
detected in the wild-type kidneys.
In conditional knock-out mice, the tissue speciﬁc deletion of Fgf8
and Lim1 from the metanephric mesenchyme (Grieshammer et al.,
2005; Kobayashi et al., 2005) resulted in a kidney phenotype similar
to the one observed in our mice, although the developmental arrest of
the Fgfrl1 deﬁcient kidneys appears to occur at an earlier stage than
that found in the Fgf8 and Lim1 mutant mice. In both of the latter
animals, nephrogenesis was initiated in the metanephric mesen-
chyme, but nephron development was arrested at the renal vesicle
stage. In contrast, we did not ﬁnd any renal vesicles in our mice. Wnt4
has been reported to be required for the initial mesenchymal-to-
epithelial transition, as Wnt4 mutant mice did not develop any
nephron precursor structures such as renal vesicles (Stark et al.,
1994). The absence of Wnt4 expression in the Fgfrl1-/- kidney
rudiments could therefore explain the lack of mesenchymal to
epithelial conversion that we observed. The severely hypoplastic
kidneys of theWnt4mutant mice (Kobayashi et al., 2005; Stark et al.,
1994) closely resemble the rudimentary kidney structures that we
found in the Fgfrl1-/- mice.
Failure of mesenchymal induction
Taken together, our data suggest that the uninduced Fgfrl1deﬁcient
metanephricmesenchyme, as speciﬁed by the nearly intact expression
of Pax2,Wt1, Eya1 and Six2 (Carroll et al., 2005), was not only present,
but was also clearly capable of inducing budding, invasion and some
branching of the ureteric bud. During this invasion and branching
process, the epithelial cells of the ureter produce and secrete Wnt9b,
which induces Fgf8, Pax8 andWnt4 and subsequently Lim1 expression
in the surroundingmesenchymal cells in a paracrine fashion (Carroll et
al., 2005). Our real-time PCR results and the in situ hybridizations
indicate thatWnt9bwas still expressed by the Fgfrl1 deﬁcient ureteric
epithelium, while Fgf8, Pax8, Wnt4 and Lim1 expression was not
induced in the mesenchyme. Apparently, the mesenchyme remained
in its uninduced state, failed to express these critical tubulogenic
markers and consequently did not initiate nephrogenesis.
The defect inmesenchymal nephrogenesis was accompanied by an
arrest of ureteric branching, which is similar to the abrupt arrest of
ureteric outgrowth observed in Wnt4 and Wnt9b deﬁcient animals
(Stark et al., 1994; Carroll et al., 2005). We assume that this is a
secondary defect due to a loss of reciprocal inductive signals from the
mutant mesenchyme. Our real-time PCR data indicated that Gdnf and
especially c-Ret expression were reduced at E14.5. Since Gdnf and its
receptor c-Ret are critical for the initial budding of the ureter and for
the maintenance of ureteric branching morphogenesis (Dressler,
2006), it is possible that this reduction ultimately led to the arrest of
ureteric outgrowth.
Most likely as a consequence of a prolonged lack of induction and
of missing survival signals from differentiating nephrons, we alsodetected a loss of Pax2 positive nephrogenic precursor cells and an
increase of apoptotic cells in the cortical zone of the remnant kidney at
E14.5. The observation that the pattern of apoptotic cells resembles
the aberrant cell death found in kidneys of mice deﬁcient in Fgf8
mediated survival signals (Grieshammer et al., 2005) is in agreement
with this hypothesis. The decrease of mesenchymal proliferation
detected in our mutant organ cultures together with the increase in
cell death in our knock-out animals might explain why only a small
number of Pax2 positive nephron precursor cells was left around the
ureteric tips of the mutant kidney at E14.5.
With regard to the molecular events that underlie the failure of
mesenchymal induction and tubulogenesis in the Fgfrl1-/- kidneys,
we can only speculate. Several Fgf ligands and receptors have been
shown to be important during early kidney development. Compound
deletion of Fgfr1 and Fgfr2 from the metanephric mesenchyme
resulted in renal aplasia due to a loss of proper mesenchyme
formation (Poladia et al., 2006). We have shown that Fgfrl1 binds
Fgf2 in vitro (Trueb et al., 2003) and that it can interfere with Fgf2
signaling in cultured cells (Rieckmann et al., 2009). It is therefore
possible that Fgfrl1 modulates Fgfr1 and/or Fgfr2 signaling in the
metanephric mesenchyme in a critical way. During developmental
processes, Fgf signaling often acts in concert with Wnt-mediated
signaling to evoke the full-blown response (Katoh and Katoh, 2006).
Fgf8 for example is needed to initiate Wnt4 expression in the
pretubular aggregates of the metanephric mesenchyme and, in turn,
Wnt4 signaling reinforces Fgf8 expression and signaling in the
nascent renal vesicle (Grieshammer et al., 2005; Schedl, 2007). With
regard to the Wnt9b mediated induction of the metanephric nephron
precursor cells, no such concomitant Fgf pathway has been described
so far. Given the strikingly similar kidney phenotypes of Wnt9b
deﬁcient mice (Carroll et al., 2005) and Fgfrl1 deﬁcient mice, one is
tempted to speculate that Fgfrl1 might mediate or modulate an Fgf
signal that acts in concert with Wnt9b to initiate the tubulogenic
program in nephron precursor cells.
An alternative explanation could lie in the fact that Fgfrl1 displays
similarities with other Ig-domain superfamily members that are
involved in cell adhesion and cell-cell recognition. We have shown
that Fgfrl1 forms constitutive dimers that are enriched at sites of cell-
cell contact and that promote cell adhesion (Rieckmann et al., 2008).
In light of this observation, it is conceivable that Fgfrl1 is required to
establish cell–cell contacts and thereby cell identity in pretubular
aggregates and structures derived thereof. The dramatic effect of
Fgfrl1 deﬁciency on nephrogenesis and the widespread expression of
Fgfrl1 in other developing tissues certainly warrant further investiga-
tion into this novel receptor molecule.
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